Evidence-based guideline: Treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology

Neurology. 2013 Oct 15;81(16):1474. doi: 10.1212/WNL.0b013e3182a7afaf.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Academies and Institutes / standards*
  • Albendazole / therapeutic use*
  • Anticestodal Agents / therapeutic use*
  • Evidence-Based Medicine*
  • Female
  • Humans
  • Male
  • Neurocysticercosis / drug therapy*
  • Neurology / standards*

Substances

  • Anticestodal Agents
  • Albendazole